TrialThe Journal of experimental medicine2008

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.

Alexandre Harari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.